A study published Online First by Archives of Neurology, a JAMA Network publication, reveals that patients with mild to moderate Alzheimer disease who received immunotherapy with the antibody bapineuzumab showed decreases in a cerebrospinal fluid biomarker. According to the researchers the results may indicate subsequent effects on the degenerative process... Via - http://www.medicalnewstoday.com/articles/243799.php
কোন মন্তব্য নেই:
একটি মন্তব্য পোস্ট করুন